GlassScriptPhysician profile
Patrick M Wirtz
NPI 1881851467
$6,392.94
in general payments reported to CMS, 2019-2025
46 companies · $1,555 in 2025
The $1,555 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $556 · 2021: $845 · 2022: $761 · 2023: $1,212 · 2024: $973 · 2025: $1,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,700 · Education: $40.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,699.93 |
| Education | $40.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $927.73 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Janssen Biotech, INC. | $678.77 | 2019-2025 | Erleada, Akeega |
| Calyxo, INC. | $434.33 | 2022-2025 | Cvac Aspiration System |
| Teleflex LLC | $428.84 | 2021-2025 | Urolift |
| Urogen Pharma, INC. | $392.00 | 2020-2024 | Jelmyto |
| Sumitomo Pharma America, INC. | $384.31 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $298.24 | 2019-2025 | Provenge |
| Abbvie INC. | $290.78 | 2023-2025 | Botox |
| Ferring Pharmaceuticals INC. | $278.35 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $247.20 | 2019-2025 | |
| Pfizer INC. | $236.98 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $212.23 | 2019-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Axonics, INC. | $156.97 | 2020-2022 | |
| Coloplast Corp | $142.95 | 2020-2022 | |
| Neotract INC. | $134.47 | 2020 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Wirtz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.